| scholarly article | Q13442814 |
| P50 | author | Subha Madhavan | Q106814502 |
| P2093 | author name string | Robert Clarke | |
| Rebecca B Riggins | |||
| Yuriy Gusev | |||
| Krithika Bhuvaneshwar | |||
| Laura Sheahan | |||
| Robinder Gauba | |||
| P2860 | cites work | MASTL is the human orthologue of Greatwall kinase that facilitates mitotic entry, anaphase and cytokinesis | Q24298633 |
| Cdc5L interacts with ATR and is required for the S-phase cell-cycle checkpoint | Q24317690 | ||
| Mutations of mitotic checkpoint genes in human cancers | Q24320018 | ||
| The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored | Q24607390 | ||
| miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor | Q24628906 | ||
| Induction of S-phase entry by E2F transcription factors depends on their nuclear localization | Q24644652 | ||
| Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers | Q24649562 | ||
| E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex | Q24685706 | ||
| Mutation analysis of the CHK2 gene in breast carcinoma and other cancers | Q24807365 | ||
| The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells | Q27851718 | ||
| Exploration, normalization, and summaries of high density oligonucleotide array probe level data | Q27861098 | ||
| Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis | Q28140028 | ||
| Reactome: a database of reactions, pathways and biological processes | Q28298042 | ||
| A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen | Q28306747 | ||
| Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines | Q28651483 | ||
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis | Q30004190 | ||
| Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. | Q30326722 | ||
| Spindle poisons and cell fate: a tale of two pathways. | Q30431071 | ||
| FOXM1: From cancer initiation to progression and treatment. | Q37943070 | ||
| Causes and consequences of aneuploidy in cancer. | Q37978107 | ||
| Topoisomerase 2 alpha: a real predictor of anthracycline efficacy? | Q37989074 | ||
| Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance | Q39639564 | ||
| E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells | Q39831755 | ||
| Nuclear expression of E2F4 induces cell death via multiple pathways in normal human intestinal epithelial crypt cells but not in colon cancer cells | Q40101908 | ||
| Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells | Q40637034 | ||
| Genomic structure of the human MAD2 gene and mutation analysis in human lung and breast cancers | Q40704303 | ||
| Tracking evolution of BRCA1-associated breast cancer | Q42507752 | ||
| Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. | Q43447818 | ||
| Feature extraction via composite scoring and voting in breast cancer | Q44330684 | ||
| Cell Context-Dependent Differences in the Induction of E2F-1 Gene Expression by 17β-Estradiol in MCF-7 and ZR-75 Cells | Q44405062 | ||
| Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series | Q44811326 | ||
| Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes. | Q45267349 | ||
| Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. | Q45345467 | ||
| Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications | Q46399502 | ||
| Downregulation of Aurora-A overrides estrogen-mediated growth and chemoresistance in breast cancer cells | Q46603050 | ||
| miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development. | Q48061857 | ||
| Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain. | Q48875498 | ||
| Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation. | Q53380672 | ||
| Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. | Q53431796 | ||
| Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. | Q53639627 | ||
| Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer. | Q54577077 | ||
| Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics | Q58614732 | ||
| Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members | Q72130905 | ||
| Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors | Q77361262 | ||
| Expression of E2F-4 gene in colorectal adenocarcinoma and corresponding covering mucosa: an immunohistochemistry, image analysis, and immunoblot study | Q78354866 | ||
| The humoral immune system has a key prognostic impact in node-negative breast cancer | Q81561686 | ||
| Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer | Q84556757 | ||
| Pathways to tamoxifen resistance | Q30441001 | ||
| Limits of predictive models using microarray data for breast cancer clinical treatment outcome | Q30992101 | ||
| limmaGUI: a graphical user interface for linear modeling of microarray data | Q33205531 | ||
| Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling | Q33211344 | ||
| Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen | Q33337206 | ||
| Integrative bioinformatics analysis of transcriptional regulatory programs in breast cancer cells | Q33372578 | ||
| Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Res | Q33389572 | ||
| Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer | Q33396559 | ||
| p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest | Q33719450 | ||
| Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast. | Q33759032 | ||
| The spindle checkpoint, aneuploidy, and cancer | Q33976673 | ||
| Gene expression-based prognostic signatures in lung cancer: ready for clinical use? | Q33988433 | ||
| A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer | Q34029272 | ||
| Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells | Q34152071 | ||
| Past and future of the mitotic spindle as an oncology target | Q34441105 | ||
| Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. | Q34506613 | ||
| Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes | Q34870283 | ||
| p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. | Q34973748 | ||
| Molecular signatures database (MSigDB) 3.0. | Q35019708 | ||
| Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact | Q35098543 | ||
| G-DOC: a systems medicine platform for personalized oncology | Q35238047 | ||
| Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis | Q35558134 | ||
| TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support | Q35631073 | ||
| HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy. | Q35744973 | ||
| A three-gene model to robustly identify breast cancer molecular subtypes | Q35769036 | ||
| Integrated cross-species transcriptional network analysis of metastatic susceptibility | Q35779338 | ||
| Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse | Q36166817 | ||
| The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment. | Q36249356 | ||
| Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype. | Q36391723 | ||
| Evaluation of the current knowledge limitations in breast cancer research: a gap analysis | Q36678664 | ||
| Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? | Q37114398 | ||
| Enabling personalized cancer medicine through analysis of gene-expression patterns | Q37127240 | ||
| PI3-kinase/p38 kinase-dependent E2F1 activation is critical for Pin1 induction in tamoxifen-resistant breast cancer cells | Q37461231 | ||
| A parsimonious model for gene regulation by miRNAs. | Q37638870 | ||
| P921 | main subject | in silico | Q192572 |
| P304 | page(s) | 31-51 | |
| P577 | publication date | 2013-02-13 | |
| P1433 | published in | Cancer Informatics | Q5031410 |
| P1476 | title | In silico discovery of mitosis regulation networks associated with early distant metastases in estrogen receptor positive breast cancers | |
| P478 | volume | 12 |
| Q64994392 | Computational identification of tissue-specific transcription factor cooperation in ten cattle tissues. |
| Q35620279 | ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer |
| Q27319225 | G-DOC Plus - an integrative bioinformatics platform for precision medicine. |
| Q26799650 | Genes Regulating Epithelial Polarity Are Critical Suppressors of Esophageal Oncogenesis |
| Q37212928 | Incorporating prior knowledge into Gene Network Study |
| Q92281961 | LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer |
| Q89782326 | NF-YA Overexpression in Lung Cancer: LUAD |
| Q90044977 | Overexpression and alternative splicing of NF-YA in breast cancer |
Search more.